• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROMODULATION SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROMODULATION SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE Back to Search Results
Model Number 8637-20
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fatigue (1849); Low Blood Pressure/ Hypotension (1914); Muscle Weakness (1967); Overdose (1988); Complaint, Ill-Defined (2331)
Event Date 03/05/2018
Event Type  Injury  
Manufacturer Narrative
Please refer to regulatory report # 3007566237-2018-00910 for the reference of the unidentified pump issue with the previous pump.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Information was received from a foreign health care provider (hcp) via a manufacturer representative regarding a patient who received an unknown drug in an implantable pump for an unknown indication for use.It was reported an overdose experience/symptoms occurred after replacement.No further information was provided.Additional information was received.It was reported the pump was implanted on (b)(6) 2018 , and the event occurred on the same date.Prior to the pump replacement, there was concern regarding a possible unidentified fault in the pump system, as spasm control had been lost.It was stated the previous pump had been set to a dose of 900 mcg/day.Following implant of the new pump, they were concerned that if the unidentified problem had been corrected, then the previous dose of 900 mcg/day could result in overdose.The new pump was set to a reduced dose of 500 mcg/day, with arrangements to monitor the patient in the high dependency unit (hdu).The concentration of baclofen used was 3000 mcg/ml.At approximately 02:00, the patient's vital signs began to raise concern, and overdose symptoms began to emerge.The patient became hypotensive with systolic blood pressure less than 80, they were increasingly drowsy but arousable, and their lower limbs became totally flaccid to passive movement.Troubleshooting included the monitoring system which was set up prior to the incident occurring so that the emerging overdose situation was quickly spotted.The pump was switched to minimum rate for a period of approximately 5 hours.During this period, the lower limb muscle tone began to increase, blood pressure returned to the previous level, and the patient became wakeful.The infusion was then recommenced at a further reduced rate of 200 mcg/day.Pump logs were not available.No further complications were reported or anticipated.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
The name of the initial reporter and facility involved in the event were provided.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNCHROMED II
Type of Device
PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
Manufacturer (Section D)
MEDTRONIC NEUROMODULATION
7000 central avenue ne rcw215
minneapolis MN 55432
Manufacturer (Section G)
MEDTRONIC NEUROMODULATION
7000 central avenue ne rcw215
minneapolis MN 55432
Manufacturer Contact
lisa woodward clark
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263920
MDR Report Key7379887
MDR Text Key103775365
Report Number3007566237-2018-00911
Device Sequence Number1
Product Code LKK
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P860004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Nurse
Type of Report Initial,Followup,Followup
Report Date 07/03/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/28/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/14/2019
Device Model Number8637-20
Device Catalogue Number8637-20
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/20/2018
Date Device Manufactured08/14/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age22 YR
-
-